Business
Apyx Medical Corporation Announces Board Leadership Transition
Andrew Makrides Retiring Following More Than 40 Years of Service as Chairman of the Board of Directors; Stavros Vizirgianakis Appointed to Succeed Mr.
About this update from Apyx Medical Corporation
[{"type":"text","content":"\nAndrew Makrides Retiring Following More Than 40 Years of Service as Chairman of the Board of Directors;\nStavros Vizirgianakis Appointed to Succeed Mr. Makrides as Chairman\n\n\n CLEARWATER, Fla.--(BUSINESS WIRE)--\nApyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced the retirement of Andrew Makrides as Chairman of the Board, after serving the Company in this position since 1982. The Board of Directors has appointed Stavros Vizirgianakis Chairman of the Board, effective as of May 7, 2024.\n\n\n“On behalf of the entire organization, I would like to express our gratitude to Andrew for his leadership and the immense contributions made during his more than 40-year tenure at Apyx Medical,” said Charlie Goodwin, President and Chief Executive Officer. “Andrew has served continuously as Chairman of the Board since co-founding Apyx Medical in 1982, while also leading the Company in multiple senior leadership roles, including as its President from 1985 until 2011 and Chief Executive Officer from 1998 until 2013. His dedication, vision and thoughtful guidance have been instrumental to the development of our organization from a start-up to a leading, Nasdaq-listed, advanced energy company serving customers in more than 60 countries. We wish him the best in his future endeavors as he begins retirement.”\n\n\nMr. Goodwin continued: “I am also pleased to welcome Stavros to the Chairman role, who joins our Board of Directors following an impressive career in the medical device industry, including significant leadership experience as both a director and senior executive of publicly-traded medical device companies. I look forward to working together as we pursue the next stage of growth for Apyx Medical.”\n\n\n“It has been one of the greatest privileges of my life to serve Apyx Medical and its stakeholders, while working alongside so many talented individuals during my tenure,” said Andrew Makrides. “Thank you to my fellow board members, and everyone who I have worked with, for your support. I look forward to the Company’s future success under new leadership and believe it is well-positioned to build upon the many achievements we have made in recent years.”\n\n\n“I am honored to be named Chairman of t...